HIPO Stock Cash Flow Statements

Hippo Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Hippo Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31

cash flows from operating activities:
net cash from operating activities	24,700,000	-35,600,000	-6,400,000	46,800,000	-10,600,000	17,700,000	-48,500,000	1,100,000	-9,300,000	-35,700,000	-30,100,000	-43,000,000	-29,800,000	-58,600,000	2,600,000
capex	-3,500,000	-2,900,000	-1,400,000	-3,400,000	-3,800,000	-3,400,000	-4,500,000	-4,700,000	-4,600,000	-3,900,000	-3,500,000	-5,500,000	-4,500,000	-6,200,000	-12,600,000
free cash flows	21,200,000	-38,500,000	-7,800,000	43,400,000	-14,400,000	14,300,000	-53,000,000	-3,600,000	-13,900,000	-39,600,000	-33,600,000	-48,500,000	-34,300,000	-64,800,000	-10,000,000
cash flows from investing activities:
capitalized internal use software costs	-3,500,000	-2,800,000	-1,300,000	-3,400,000	-3,700,000	-3,300,000	-4,100,000	-4,500,000	-4,600,000	-3,900,000	-3,400,000	-3,700,000	-3,900,000	-3,800,000	-11,900,000
purchases of property and equipment		-100,000	-100,000	0	-100,000	-100,000	-400,000	-200,000			-100,000	-1,800,000	-600,000	-2,400,000	-700,000
purchases of fixed maturities	-33,700,000	-15,700,000	-27,000,000	-46,700,000	-6,700,000	-17,300,000
maturities of fixed maturities	9,200,000	11,200,000	19,900,000	11,000,000	3,800,000	14,400,000
sales of fixed maturities			0	0	800,000	600,000
purchases of short-term investments	-98,300,000	-50,400,000	-97,100,000	-58,200,000	-77,200,000	-37,600,000
maturities of short-term investments	99,800,000	46,800,000	79,600,000	50,000,000	54,800,000	101,800,000
sales of short-term investments			0	0
net cash from investing activities	-21,900,000	-11,000,000	27,800,000	-27,900,000	-28,100,000	58,500,000	-22,000,000	30,800,000	35,000,000	13,800,000	-115,200,000	112,500,000	-25,000,000	-378,200,000	-7,100,000
cash flows from financing activities:
proceeds from surplus note
taxes paid related to net share settlement of equity awards	-2,100,000	-3,300,000	-3,600,000	-2,500,000	-2,700,000	-1,100,000	-700,000	-1,100,000	-2,000,000	-900,000	-400,000	-800,000	-1,700,000	-1,000,000
proceeds from issuance of common stock	1,300,000	1,000,000	3,700,000	800,000	1,200,000	1,000,000
payments of contingent consideration	-200,000	-200,000	-200,000	-200,000	-200,000	-300,000	-300,000	-300,000	-300,000	-400,000					-600,000
distributions to noncontrolling interests and other	-4,100,000	-3,500,000	-3,800,000	-6,100,000	-2,700,000	-7,600,000
net cash from financing activities	42,800,000	-6,000,000	-19,500,000	-8,200,000	-4,400,000	-8,000,000	-3,800,000	-900,000	-8,000,000	-1,900,000	-3,100,000	-1,100,000	-2,300,000	-300,000	400,000
net increase in cash, cash equivalents, and restricted cash	45,600,000	-52,600,000	1,900,000	10,700,000	-43,100,000	68,200,000				-23,800,000	-148,400,000	68,400,000	-57,100,000	-437,100,000	-4,100,000
cash, cash equivalents, and restricted cash at the beginning of the period	0	232,800,000	0	0	0	195,100,000	0	0	0	244,500,000	0	0	0	818,700,000	0
cash, cash equivalents, and restricted cash at the end of the period	45,600,000	180,200,000	1,900,000	10,700,000	-43,100,000	263,300,000	-74,300,000	31,000,000	17,700,000	220,700,000	-148,400,000	68,400,000	-57,100,000	381,600,000	-4,100,000
net income			46,900,000	-5,200,000	-37,200,000	-33,100,000	-39,300,000	-50,300,000	-105,300,000	-68,100,000	-60,500,000	-127,500,000	-72,000,000	-66,500,000	-59,300,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization			5,800,000	5,900,000	5,900,000	5,600,000	5,400,000	4,900,000	5,200,000	4,300,000	4,000,000	3,800,000	3,500,000	3,900,000	3,300,000
stock–based compensation expense			8,900,000	9,000,000	11,900,000	8,400,000	10,800,000	13,900,000	16,700,000	16,100,000	15,600,000	17,000,000	15,900,000	13,400,000
fair value adjustments			-500,000	300,000	400,000	1,500,000
impairment and restructuring charges			0	0
gain on sale of business			-46,200,000
other non-cash items			400,000	-2,000,000	-2,200,000	-2,400,000	-500,000	-2,100,000	-3,000,000	-1,800,000	-2,700,000	-500,000	0	200,000
changes in assets and liabilities:
accounts receivable			-9,300,000	9,600,000	-13,500,000	-8,700,000	200,000	2,800,000	-14,600,000	-26,400,000	-17,600,000	-23,200,000	-5,600,000	-4,500,000	2,900,000
reinsurance recoverable on paid and unpaid losses and lae			-5,500,000	11,000,000	-700,000	-8,800,000	16,000,000	35,700,000	-32,100,000	-14,600,000	51,000,000	-45,900,000	30,000,000	-54,500,000	12,500,000
ceding commissions receivable			9,600,000	-7,400,000	500,000	-8,400,000	6,200,000	-9,900,000	-10,200,000	-14,100,000	10,500,000	-6,300,000	-800,000	-7,600,000	-3,600,000
prepaid reinsurance premiums			18,100,000	-1,000,000	-16,000,000	60,300,000	40,000,000	-300,000	-48,500,000	-16,900,000	-8,300,000	-38,200,000	-27,400,000	-4,400,000	-3,500,000
other assets			-200,000	-100,000	-2,800,000	-3,300,000	6,100,000	2,800,000	-600,000	-2,100,000	-6,400,000	6,200,000	12,400,000	-3,300,000	-200,000
benefit from commission			3,300,000	-200,000	2,300,000	4,300,000	6,700,000	5,300,000	4,000,000	3,700,000	-8,400,000	100,000	-1,100,000	2,100,000	1,000,000
accrued expenses and other liabilities			-8,100,000	-4,900,000	1,600,000	-6,100,000	-12,100,000	-1,700,000	3,300,000	5,000,000	4,100,000	8,200,000	9,600,000	-2,300,000	16,400,000
loss and loss adjustment expense reserves			-1,100,000	4,200,000	10,300,000	14,100,000	-37,400,000	-7,700,000	62,400,000	11,400,000	-27,700,000	52,700,000	-13,600,000	21,600,000	21,100,000
unearned premiums			-15,900,000	21,100,000	45,500,000	-12,000,000	-22,700,000	18,800,000	57,400,000	24,400,000	24,800,000	33,600,000	30,800,000	-1,000,000	8,800,000
reinsurance premiums payable			-12,600,000	14,700,000	-16,600,000	3,000,000	-31,000,000	-11,700,000	53,300,000	42,400,000	-8,800,000	23,500,000	-9,300,000	42,300,000	-2,800,000
assets disposed from sale of business
proceeds from sale of business, net of cash disposed			48,000,000
other			0				-2,300,000	0	100,000	-1,000,000	0	0	0	-2,000,000	-8,900,000
share repurchases under program							0	0	-1,600,000	-200,000
acquisitions of noncontrolling interests			0
impairment charges						3,300,000					0
other changes in fair value
change in fair value of contingent consideration liability							1,500,000	800,000	2,900,000	800,000	1,500,000	200,000	-800,000	3,200,000	1,400,000
net decrease in cash, cash equivalents, and restricted cash
change in fair value of warrant liability										200,000	-1,200,000	-200,000	-1,400,000	-1,200,000	-4,700,000
purchases of investments								-83,500,000	-96,000,000	-111,200,000	-147,600,000	-237,400,000	-22,600,000	-385,400,000	-1,400,000
maturities of investments								119,300,000	142,300,000	122,000,000	34,200,000	354,100,000	500,000	12,800,000	3,800,000
sales of investments								-300,000	22,200,000	7,900,000	1,700,000	1,300,000	1,600,000	2,600,000	5,100,000
proceeds from issuances of common stock								500,000				100,000
distributions to noncontrolling interests								0
proceeds from exercise of options										200,000				1,200,000	1,600,000
change in fair value of preferred stock warrant liabilities															0
change in fair value of derivative liability on notes															0
amortization of debt discount															0
gain on extinguishment of debt															0
non-cash interest expense
non-cash service expense															0
purchase of intangible assets															0
proceeds from the exercise of preferred stock warrants															0
proceeds from reverse recapitalization, net of redemptions, secondaries and costs															1,000,000
supplemental disclosures of non-cash financing and investing activities:
payments for reverse recapitalization and transaction costs
conversion of preferred stock for common stock
acquisition of public and private placement warrants
equity issued for acquisitions
unpaid transaction costs
convertible promissory notes issued for services
cash paid for acquisitions, net of cash acquired															0
proceeds from series d preferred stock, net of issuance costs
proceeds from series e preferred stock, net of issuance costs
proceeds from promissory notes, net of issuance costs
share–based compensation expense
fiduciary liabilities

We provide you with 20 years of cash flow statements for Hippo stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hippo stock. Explore the full financial landscape of Hippo stock with our expertly curated income statements.

The information provided in this report about Hippo stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.